Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 48 citing articles:

Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
Julia M. Flynn, Neha S. Samant, Gily Schneider-Nachum, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 95
Cys44 of SARS-CoV-2 3CLpro affects its catalytic activity
Ilaria Iacobucci, Irene Cipollone, Flora Cozzolino, et al.
International Journal of Biological Macromolecules (2025), pp. 139590-139590
Closed Access | Times Cited: 1
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
Matteo Pavan, Giovanni Bolcato, Davide Bassani, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1645-1649
Open Access | Times Cited: 67
Diphenyl Diselenide and SARS-CoV-2: in silico Exploration of the Mechanisms of Inhibition of Main Protease (Mpro) and Papain-like Protease (PLpro)
Folorunsho Bright Omage, Andrea Madabeni, Amanda Resende Tucci, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 7, pp. 2226-2239
Open Access | Times Cited: 20
Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method
Lanlan Jing, Fabao Zhao, Lin Zheng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 670-670
Open Access
Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition
Muzaffar Kayumov, Parthiban Marimuthu, Jamoliddin Razzokov, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Revealing the impact of active site residues in modeling the inhibition mechanism of SARS-Cov-2 main protease by GC373
Mohamed M. Aboelnga, Maya Petgrave, Subha Kalyaanamoorthy, et al.
Computers in Biology and Medicine (2025) Vol. 187, pp. 109779-109779
Closed Access
SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations
Roman S. Tumskiy, Anastasiia V. Tumskaia, Iraida Nikolaevna Klochkova, et al.
Computers in Biology and Medicine (2022) Vol. 153, pp. 106449-106449
Open Access | Times Cited: 24
Multi-ligand molecular docking, simulation, free energy calculations and wavelet analysis of the synergistic effects between natural compounds baicalein and cubebin for the inhibition of the main protease of SARS-CoV-2
Hong Li, Akari Komori, Mingdi Li, et al.
Journal of Molecular Liquids (2023) Vol. 374, pp. 121253-121253
Open Access | Times Cited: 13
Identification of Pyrazole Derivatives of Usnic Acid as Novel Inhibitor of SARS-CoV-2 Main Protease Through Virtual Screening Approaches
Miah Roney, Gagandeep Singh, AKM Moyeenul Huq, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 4, pp. 696-706
Open Access | Times Cited: 13
Novel series of hydrazones carrying pyrazole and triazole moiety: Synthesis, structural elucidation, quantum computational studies and antiviral activity against SARS-Cov-2
D.V. Geetha, Chigahally Lakshmegowda Sharath, N. Shivakumar, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139016-139016
Closed Access | Times Cited: 3
Dynamic allostery highlights the evolutionary differences between the CoV-1 and CoV-2 main proteases
Paul Campitelli, Lu Jin, S. Banu Ozkan
Biophysical Journal (2022) Vol. 121, Iss. 8, pp. 1483-1492
Open Access | Times Cited: 15
Novel covalent and non-covalent complex-based pharmacophore models of SARS-CoV-2 main protease (Mpro) elucidated by microsecond MD simulations
Yasser Hayek-Orduz, Andrés Felipe Vásquez, Maria F. Villegas-Torres, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Structure-Based Discovery of Allosteric Inhibitors Targeting a New Druggable Site in the Respiratory Syncytial Virus Polymerase
Ahmed K. Oraby, Leanne M. Bilawchuk, F. G. West, et al.
ACS Omega (2024)
Open Access | Times Cited: 2
Pre‐exascale HPC approaches for molecular dynamics simulations. Covid‐19 research: A use case
Miłosz Wieczór, Vito Genna, Juan Aranda, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease
Norman Tran, Sathish Dasari, Sarah Barwell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CLPro and PLPro) by Molecular Docking and Dynamic Simulation Studies
Quaiser Saquib, Ahmed H. Bakheit, Sarfaraz Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 998-998
Open Access | Times Cited: 1
Computational methods meet in vitro techniques: A case study on fusaric acid and its possible detoxification through cytochrome P450 enzymes
Lorenzo Pedroni, Daniel Z. Doherty, Chiara Dall’Asta, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 273, pp. 116167-116167
Open Access | Times Cited: 1
Mapping protein conformational landscapes from crystallographic drug fragment screens
Ammaar A. Saeed, Margaret A. Klureza, Doeke R. Hekstra
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
In-silico evaluation of phytochemicals for vitiligo: ADMET, molecular docking, and MD simulation approaches
Acharya Balkrishna, Anurag Dabas, Netrapal Singh, et al.
Natural Product Research (2024), pp. 1-13
Closed Access | Times Cited: 1
Virus structure and structure-based antivirals
Z Plavec, Ina Pöhner, Antti Poso, et al.
Current Opinion in Virology (2021) Vol. 51, pp. 16-24
Open Access | Times Cited: 12
In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2
Amit Kumar Srivastav, Jyoti Jaiswal, Umesh Kumar
Journal of Biomolecular Structure and Dynamics (2021) Vol. 41, Iss. 5, pp. 1574-1585
Closed Access | Times Cited: 11
MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2
Monica Sharma, Jai Krishna Mahto, Preeti Dhaka, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 22, pp. 12048-12061
Open Access | Times Cited: 9
Molecular insights into the anti‐inflammatory activity of fermented pineapple juice using multimodal computational studies
Trina Ekawati Tallei, Fatimawali Fatimawali, Ahmad Akroman Adam, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Closed Access | Times Cited: 3
Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host
Shivangi Agrawal, Ekta Pathak, Rajeev Mishra, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 106049-106049
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top